Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens

Clinical and Translational Allergy

Volumn 4, Issue 1, 2014, Pages

  Trebuchon, Florence ^a,d   Lhéritier Barrand, Michèle ^b   David, Marie ^b   Demoly, Pascal ^c  

^a Private Office   (France)

^b Stallergenes SA   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d 3 Chemin du Fescau ^*  (France)

Author keywords

Adolescents; Allergy; Asthma; Children; House dust mite; Rhinitis; Sublingual immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING BETA AGONIST; SHORT ACTING BETA AGONIST; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC RHINITIS; ANOSMIA; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; COUGHING; EYE DISEASE; FEMALE; FRANCE; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NOSE OBSTRUCTION; PATIENT COMPLIANCE; PATIENT SAFETY; PATIENT SATISFACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHINITIS; RHINORRHEA; SCHOOL CHILD; SKIN TEST; SNEEZING; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; WHEEZING;

EID: 84978023516     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/2045-7022-4-15     Document Type: Article

References (22)

1. Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, Schleimer RP, Ledford D: Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of allergy and clinical immunology and the American academy of allergy, Asthma & immunology. J Allergy Clin Immunol 2013, 131:1479-1490.
2. Bousquet PJ, Bousquet-Rouanet L, Co Minh HB, Urbinelli R, Allaert FA, Demoly P: ARIA (Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France. Int Arch Allergy Immunol 2007, 143:163-169.
3. Radulovic S, Calderon MA, Wilson D, Durham S: Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010, (12): Art. No.: CD002893. doi:10.1002/14651858.CD002893.pub2.
4. Antunez C, Mayorga C, Corzo JL, Jurado A, Torres MJ: Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 2008, 19:210-218.
5. Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C: Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol 2013, 131:1361-1366.
6. Kim JM, Lin SY, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, Erekosima N: Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics 2013, 131:1155-1167.
7. Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB: Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013, 309:1278-1288.
8. Radulovic S, Wilson D, Calderon M, Durham S: Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011, 66:740-752.
9. Bahçeciler NN, Isik U, Barlan IB, Basaran MM: Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001, 32:49-55.
10. Compalati E, Passalacqua G, Bonini M, Canonica GW: The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009, 64:1570-1579.
11. Han DH, Choi YS, Lee JE, Kim DY, Kim JW, Lee CH, Rhee CS: Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients. Acta Otolaryngol 2012, 132(Suppl 1):S88-S93.
12. Lombardi C, Gani F, Landi M, Falagiani P, Bruno M, Canonica GW, Passalacqua G: Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004, 113:1219-1220.
13. Passalacqua G, Musarra A, Pecora S, Amoroso S, Antonicelli L, Cadario G, di Gioacchino M, Lombardi C, Ridolo E, Sacerdoti G, Schiavino D, Senna G: Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007, 18:58-62.
14. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schunemann HJ: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010, 126:466-476.
15. de Bot CM, Moed H, Berger MY, Roder E, Hop WC, de Groot H, de Jongste JC, van Wijk RG, Bindels PJ, van der Wouden JC: Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Pediatr Allergy Immunol 2012, 23:150-158.
16. Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB: Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012, 157:288-298.
17. Trebuchon F, David M, Demoly P: Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: a retrospective, observational study. Int J Immunopathol Pharmacol 2012, 25:193-206.
18. Passalacqua G, Baena-Cagnani CE, Bousquet J, Canonica GW, Casale TB, Cox L, Durham SR, Larenas-Linnemann D, Ledford D, Pawankar R, Potter P, Rosario N, Wallace D, Lockey RF: Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol 2013, 132:93-98.
19. Incorvaia C, Mauro M, Ridolo E, Puccinelli P, Liuzzo M, Scurati S, Frati F: Patient's compliance with allergen immunotherapy. Patient Prefer Adherence 2008, 2:247-251.
20. Larenas-Linnemann D, Blaiss M, van Bever HP, Compalati E, Baena-Cagnani CE: Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012. Ann Allergy Asthma Immunol 2013, 110:402-415.
21. Wilson DR, Irani AM, Walker SM, Jacobson MR, Mackay IS, Schwartz LB, Durham SR: Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001, 31:1705-1713.
22. Moingeon P: Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol 2013, 1:228-241.